Worksite Labs, INC.

Worksite Labs, INC. was paid $2.26M by Medicaid between Aug 2021 and Sep 2023, across 5 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 74% of everything it billed.

33Billing provider infoWORKSITE LABS, INC.
PLACENTIA, CA 92870

33aNPI1467030536assigned 03/31/2021

33bProvider typeClinical Medical Laboratory

28Total paid$2.26M

24GClaims55,128

24DCodes billed5

24AFirst – last monthAug 2021 – Sep 2023

Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#142 of 561

Median peer was paid$222K

This provider vs. median10×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	2,564	$75K
2022	40,479	$1.60M
2023	12,085	$578K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	74%	26,682	12,636	$1.67M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	14%	17,613	8,162	$327K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	5.6%	2,823	1,032	$126K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	5.4%	7,599	6,131	$122K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	411	335	$12K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFRAZIER, GARY (CEO)

Same official

Other billing entities under FRAZIER, GARY

Full network →

Provider	Location	Paid
Aleph Lab, LLC	Walnut Creek, CA	$14K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.